Showing results (101-110 of 332) with videos related to

Sort By:
Pageof 34
Bulletin Du Cancer|October 7, 2019
[Haploidentical hematopoietic stem cell transplant: How to choose the best donor? Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Valérie Dubois, Kahina Amokrane, Yves Beguin, et al.
Blood Advances|October 31, 2025
Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-AML activityMaxime Jullien, Enora Ferron, Catherine Willem, et al.
Journal of Hematology & Oncology|November 29, 2022
Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TCLudovic Jondreville, Maud D'Aveni, Hélène Labussière-Wallet, et al.
Transplantation and Cellular Therapy|June 17, 2022
Impact of the Addition of Antithymocyte Globulin to Post-Transplantation Cyclophosphamide in Haploidentical Transplantation with Peripheral Blood Compared to Post-Transplantation Cyclophosphamide Alone in Acute Myelogenous Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationGiorgia Battipaglia, Myriam Labopin, Didier Blaise, et al.
Leukemia & Lymphoma|November 6, 2020
Blinatumomab + ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adultsMarie-Anne Couturier, Xavier Thomas, Emmanuel Raffoux, et al.
Bone Marrow Transplantation|June 30, 2022
Outcome of human umbilical cord blood stem cell transplantation (CBT) for acute myeloid leukemia in patients achieving first complete remission after one versus two induction courses: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Arnon Nagler, Myriam Labopin, Jan J Cornelissen, et al.
Haematologica|April 17, 2025
A phase II study of ponatinib for prevention of relapse after allotransplantation in <i>FLT3</i> internal tandem duplication mutation positive (FLT3-ITD+) acute myeloid leukemia: the PONALLO trialPatrice Chevallier, Anne Thiebaut, Sylvie François, et al.
Bone Marrow Transplantation|September 19, 2019
Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT studyKatie S Gatwood, Myriam Labopin, Bipin N Savani, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 21, 2026
Infectious events in fit patients with relapsed or refractory acute myeloid leukemia treated with azacitidine-venetoclax or intensive chemotherapyMaxime Bobo, Lucas Lefevre, Paul Mallet-Guy, et al.
Oncotarget|December 20, 2018
Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TCAmandine Le Bourgeois, Myriam Labopin, Mathieu Leclerc, et al.
Pageof 34